Adagio Medical Holdings (ADGM) Revenue (2023 - 2024)
Adagio Medical Holdings' (ADGM) quarterly Revenue came in at $132000.0 in Q3 2024, up 221.95% year-over-year from $41000.0 in Q4 2023, and down 48.03% quarter-over-quarter from $254000.0 in Q2 2024.
Powered by 
Analysis
Adagio Medical Holdings (ADGM) Revenue (2023 - 2024) Analysis & Trends
Adagio Medical Holdings has disclosed Revenue across 2 years of filings, most recently posting $132000.0 for Q3 2024.
- In Q3 2024, Revenue rose 221.95% year-over-year to $132000.0; the TTM figure through Sep 2025 stood at $132000.0 (down 73.06% YoY), while the FY2024 annual figure was $269000.0, down 10.33% from the prior year.
- Revenue came in at $132000.0 for Q3 2024 at Adagio Medical Holdings, down from $254000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $254000.0 in Q2 2024 to a low of $26000.0 in Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 2.89 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 9.76 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 6.59 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 5.44 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 1.74 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 2.78 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 1.31 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 1.49 Bn |
| 10 | Adagio Medical Holdings | 13.45 Mn | 13.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 254,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 78,000.00 |
| Sep 30, 2023 | 41,000.00 |